# Medications Development for the Treatment of Cannabis Related Disorders

> **NCT01204723** · PHASE1 · COMPLETED · sponsor: **University of Virginia** · enrollment: 63 (actual)

## Conditions studied

- Nicotine Withdrawal
- Marijuana Dependence
- Cannabis Dependence
- Nicotine Dependence
- Cannabis Abuse

## Interventions

- **DRUG:** Placebo Aprepitant
- **DRUG:** Active Aprepitant

## Key facts

- **NCT ID:** NCT01204723
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-04
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2012-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204723, "Medications Development for the Treatment of Cannabis Related Disorders". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01204723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*